194 filings
6-K
CYBN
Cybin Inc.
6 May 24
Cybin Provides Corporate Update and Highlights Upcoming Clinical Milestones
5:19pm
6-K
CYBN
Cybin Inc.
25 Apr 24
Cybin to Participate at the 27th Annual Milken Institute Global Conference
3:19pm
6-K
CYBN
Cybin Inc.
18 Apr 24
Cybin Announces Publication of Research Manuscript in the Journal of Medicinal Chemistry
3:12pm
6-K
CYBN
Cybin Inc.
18 Apr 24
Current report (foreign)
9:03am
6-K
CYBN
Cybin Inc.
16 Apr 24
Cybin Announces Grant of Additional U.S. Patent in Support of its CYB003 Breakthrough Therapy Program for Major Depressive Disorder
3:36pm
6-K
0nwh917
10 Apr 24
Cybin to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
5:23pm
6-K
b6se qn0q9rqi
22 Mar 24
Material Change Report
2:41pm
6-K
v2600o
21 Mar 24
Current report (foreign)
1:55pm
6-K
bdb9alfg nx
20 Mar 24
Announces Oversubscribed Private Placement of U.S. $150 Million
3:16pm
6-K
8bq7o0
18 Mar 24
Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas
2:49pm
6-K
8erquxqm 167j
15 Mar 24
Current report (foreign)
3:19pm
6-K
9ejhrx vnxj
14 Mar 24
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
3:59pm
6-K
znfmmq336t
13 Mar 24
Current report (foreign)
4:09pm
6-K
bk438d73
13 Mar 24
Cybin to Host Conference Call and Webcast to Provide Program Update for CYB003
3:38pm
6-K
ldayjramyz
27 Feb 24
Cybin to Present at the TD Cowen 44th Annual Health Care Conference
1:34pm
6-K/A
28mbkfh0yy3k9g921hg2
15 Feb 24
Condensed Interim Consolidated Financial Statements
11:09am
6-K
g7vk hi6jfzi24ndz
14 Feb 24
Condensed Interim Consolidated Financial Statements
8:17am
6-K
e95l4q8h ztd3fwflg
7 Feb 24
Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
12:15pm
6-K
09ridnihdu9qn
23 Jan 24
Cybin Announces FDA Clearance to Initiate a Phase 2a Study of CYB004 in Generalized Anxiety Disorder
1:19pm
6-K
cgrtmt2 2d
8 Jan 24
Cybin Announces Positive Topline Data from Phase 1 Studies of Proprietary Deuterated DMT Molecules CYB004 and SPL028
2:40pm